Biotricity (OTCMKTS:BTCY) Shares Up 0.2% – Should You Buy?

Shares of Biotricity Inc. (OTCMKTS:BTCY) were up 0.2% on Tuesday . The stock traded as high as $0.2419 and last traded at $0.2355. Approximately 913 shares were traded during mid-day trading, a decline of 97% from the average daily volume of 35,054 shares. The stock had previously closed at $0.2350.

Biotricity Stock Up 0.2%

The stock has a market capitalization of $6.74 million, a P/E ratio of -1.47 and a beta of 1.36. The business has a fifty day moving average price of $0.28 and a 200-day moving average price of $0.44.

Biotricity (OTCMKTS:BTCY) last released its quarterly earnings data on Wednesday, February 11th. The company reported ($0.04) EPS for the quarter, beating the consensus estimate of ($0.08) by $0.04. The business had revenue of $3.99 million for the quarter. On average, equities analysts expect that Biotricity Inc. will post -1.43 earnings per share for the current fiscal year.

Biotricity Company Profile

Biotricity (OTCMKTS:BTCY) is a medical device and digital health company specializing in remote cardiovascular monitoring and chronic disease management. The company’s flagship offering, the Bioflux system, integrates a wearable ECG patch with a cloud-based analytics platform to deliver real-time heart rhythm data and diagnostic insights. By combining wireless biosensors, mobile applications, and secure data transmission, Biotricity aims to simplify patient monitoring for healthcare providers and enhance early detection of arrhythmias and other cardiac events.

In addition to its core ambulatory ECG solution, Biotricity provides a suite of digital health products designed for broader chronic care management.